Infrapatellar fat pad in the knee: is local fat good or bad for knee osteoarthritis? by Weiyu Han et al.
Han et al. Arthritis Research & Therapy 2014, 16:R145
http://arthritis-research.com/content/16/4/R145RESEARCH ARTICLE Open AccessInfrapatellar fat pad in the knee: is local fat good
or bad for knee osteoarthritis?
Weiyu Han1,2, Shiji Cai1, Zhenhua Liu1,2, Xingzhong Jin1, Xia Wang1, Benny Antony1, Yuelong Cao1, Dawn Aitken1,
Flavia Cicuttini3, Graeme Jones1 and Changhai Ding1,3*Abstract
Introduction: Recent studies regarding the infrapatellar fat pad (IPFP) mainly focus on the roles of the cells derived
from the IPFP. There have been few clinical or epidemiological studies reporting on the association between the
IPFP and knee osteoarthritis (OA). Our objective is to generate hypotheses regarding the associations between IPFP
maximum area and knee OA measures in older adults.
Methods: A total of 977 subjects between 50 and 80 years of age (mean, 62.4 years) participated in the study.
Radiographic knee osteophyte and joint space narrowing (JSN) were assessed using the Osteoarthritis Research
Society International atlas. T1- or T2-weighted fat suppressed magnetic resonance imaging (MRI) was utilized to
assess IPFP maximum area, cartilage volume, cartilage defects, and bone marrow lesions (BMLs). Knee pain was
assessed by self-administered Western Ontario McMaster Osteoarthritis Index (WOMAC) questionnaire.
Results: After adjustment for potential confounders, IPFP maximum area was significantly associated with joint
space narrowing (odds ratio (OR): 0.75, 95% confidence interval (CI): 0.62 to 0.91 (medial), 0.77, 95% CI: 0.62 to 0.96
(lateral)) and medial osteophytes (OR: 0.52, 95% CI: 0.35 to 0.76), knee tibial and patellar cartilage volume (β: 56.9 to
164.9 mm3/cm2, all P <0.001), tibial cartilage defects (OR: 0.58, 95% CI: 0.41 to 0.81 (medial), 0.53, 95% CI: 0.40-0.71
(lateral)), any BMLs (OR: 0.77, 95% CI: 0.63 to 0.94), and knee pain on a flat surface (OR: 0.79, 95% CI: 0.63 to 0.98).
IPFP maximum area was negatively, but not significantly, associated with femoral cartilage defects, lateral
tibiofemoral BMLs, and total knee pain or other knee pain subscales.
Conclusion: IPFP maximum area is beneficially associated with radiographic OA, MRI structural pathology and knee
pain on a flat surface suggesting a protective role for IPFP possibly through shock absorption. Consequently, we
must pay special attention to IPFP in the clinical settings, avoiding resection of normal IPFP in knee surgery.Introduction
Osteoarthritis (OA), the most prevalent form of arthritis,
is a common cause of chronic disability in older adults
[1]. It can affect one or more joints of the body but is
most common in the knees [2]. Traditionally, it is cha-
racterized by loss of articular cartilage and formation of
osteophytes; however, evidence has emerged that OA
involves the entire joint tissues, including the menisci,
ligaments, subchondral bone, capsule, synovium, and
periarticular muscle [2,3]. Although the pathogenesis of* Correspondence: changhai.ding@utas.edu.au
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stated.knee OA is not fully elucidated, both mechanical and
metabolic factors play roles in the progression of this
disease [1,2]. Age [4], female sex [5], and body mass
index (BMI) [6] are well-known risk factors for knee
OA.
Infrapatellar fat pad (IPFP), an intracapsular but extra-
synovial structure [7], is situated in the knee under the
patella, between the patellar tendon, femoral condyle
and tibial plateau [8], and is structurally similar to sub-
cutaneous adipose tissue [9]. Recent studies [10,11]
mainly focus on the roles of the cells derived from IPFP,
such as inflammatory cells and substance P nerve cells
in OA, and consider IPFP as an active joint tissue in the
initiation and progression of knee OA [8], as inflam-
matory cells from IPFP can produce inflammatory me-
diators, which are able to influence the cartilage and. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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an important source of pain in knee OA. IPFP is com-
monly resected during knee surgery; however, IPFP lo-
cates so closely to cartilage and bone surface that it may
reduce the impact loading and absorb forces generated
through the knee joint. So far, there have been few cli-
nical or epidemiological studies [12] reporting the asso-
ciation between IPFP and knee OA measures, so the
role of IPFP in knee OA is largely unknown.
Clinical features (such as joint pain) and joint struc-
tural abnormalities such as joint space narrowing (JSN),
osteophytes, loss of cartilage volume, cartilage defects
and bone marrow lesions (BMLs) are usually used to as-
sess development/progression of knee OA [13]. The aim
of this study was, therefore, to generate hypotheses re-
garding the associations between symptoms, joint struc-
tural abnormalities and IPFP area in older adults.
Methods
Subjects
This study was conducted as part of the Tasmanian Older
Adult Cohort (TASOAC) study, an ongoing prospective,
population-based study aimed at identifying the environ-
mental, genetic, and biochemical factors associated with
the development and progression of OA (assessed by both
radiography and magnetic resonance imaging (MRI)). Sub-
jects (n = 1,100) between the age of 50 and 80 years were
randomly selected from the roll of electors in southern
Tasmania (population, 229,000), a comprehensive popula-
tion listing with an equal number of men and women. The
overall response rate was 57%. Institutionalized persons
and subjects with contraindications to MRI were excluded.
The study was approved by the Southern Tasmanian
Health and Medical Human Research Ethics Committee,
and written informed consent was obtained from all par-
ticipants. Self-report of diseases including asthma, cardio-
vascular disease, diabetes, and rheumatoid arthritis was
recorded by questionnaire.
Anthropometrics and joint pain assessment
Height was measured to the nearest 0.1 cm (with shoes,
socks, and headgear removed) using a stadiometer. Weight
was measured to the nearest 0.1 kg (with shoes, socks, and
bulky clothing removed) by using a single pair of elec-
tronic scales (Delta Model 707, Seca, Hamburg, Germany)
that were calibrated using a known weight at the begin-
ning of each clinic. BMI (weight (kg)/height (m2)) was also
calculated. Total body and trunk fat were measured by a
Hologic dual-energy x-ray absorptiometry (DXA) scanner
(Hologic Corp., Waltham, MA, USA).
The assessment of knee pain (on a flat surface, going
up/down stairs, at night, sitting/lying, and standing up-
right) was self-administered, using the Western Ontario
McMaster Osteoarthritis Index (WOMAC) with a 10-point scale from 0 (no pain, stiffness, or functional prob-
lems) to 9 (most severe) [14]. Each compartment of joint
pain was summed to create a total pain score (0 to 45),
and the presence of knee pain was defined as a total score
or a subscale score ≥1 [15,16].
Lower-limb muscle strength and knee radiographic
assessments
We used dynamometry to measure lower-limb muscle
strength twice, and took the mean as the final result, as
previously described [17,18]. A standing anteroposterior
semiflexed view of the right knee with 15 degrees of fixed-
knee flexion was performed in all subjects, and radio-
graphs were individually assessed for JSN and osteophytes
on a scale of 0 to 3 (0 = normal and 3 =most severe) using
the Osteoarthritis Research Society International (OARSI)
atlas developed by Altman et al. [19]. We summed the
osteophyte and JSN scores as the knee total radiographic
OA (ROA) score; an ROA score ≥1 was used to define the
presence of knee ROA, as previously described [20].
Magnetic resonance imaging assessment
MRI scans of the right knees were performed at baseline.
Knees were imaged in the sagittal plane on a 1.5-T whole-
body magnetic resonance unit (Picker, Cleveland, OH,
USA) with the use of a commercial transmit-receive ex-
tremity coil. The following image sequences were used: (1)
a T1-weighted fat saturation three-dimensional gradient
recall acquisition in the steady state; flip angle 30 degrees;
repetition time 31 msecs; echo time 6.71 msec; field of
view 16 cm; 60 partitions; 512 × 512 matrix; acquisition
time 11 minutes 56 sec; one acquisition. Sagittal images
were obtained at a partition thickness of 1.5 mm and an
in-plane resolution of 0.31 × 0.31 (512 × 512 pixels), and
(2) a T2-weighted fat saturation two-dimensional fast spin
echo, flip angle 90°, repetition time 3,067 ms, echo time
112 ms, field of view 16 cm, 15 partitions, 256 × 256-pixel
matrix; sagittal images were obtained at a slice thickness
of 4 mm with a interslice gap of 1.0 mm.
IPFP was measured by manually drawing disarticula-
tion contours around the IPFP boundaries (Figure 1) on
a section-by-section T2-weighted MR image, using the
software program Osiris (University of Geneva). The
maximum area was selected to represent the IPFP size.
One observer graded the IPFP area on all MRI scans.
The intraclass correlation coefficient (ICC) was 0.96 for
intra-observer reliability (measured in 40 images by one
observer), and inter-observer reliability was 0.92 (mea-
sured in 40 images by two observers).
Knee cartilage volume was determined on T1-weighted
MR images with image processing on an independent
work station, as previously described [17,18,21]. The total
cartilage volume was divided into patellar, medial and
lateral tibial cartilage volume by manually drawing
Figure 1 Measurement of infrapatellar fat pad area. The areas of
infrapatellar fat pad were measured by manually drawing disarticulation
contours around the infrapatellar fat pad boundaries on a section-by-
section T2-weighted magnetic resonance imaging. The maximum area
was selected to represent the infrapatellar fat pad area.
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section by section, which were then re-sampled for the
final three-dimensional rendering [17,18]. The coefficients
of variation (CVs) for this method in our hands were 2.1%
to 2.6% [17,18].
Cartilage defects (0 to 4 scale) were assessed at the med-
ial tibial, medial femoral, lateral tibial, lateral femoral, and
patellar sites using T1-weighted images as previously
described [22,23] and were further confirmed using
T2-weighted images as follows: grade 0 = normal cartilage;
grade 1 = focal blistering and intracartilaginous low-signal
intensity area with an intact surface; grade 2 = irregula-
rities on the surface or bottom and loss of thickness <50%;
grade 3 = deep ulceration with loss of thickness >50%;
grade 4 = full-thickness chondral wear with exposure of
subchondral bone. The presence of cartilage defect was
defined as a cartilage defect score ≥2 at one site. Intraob-
server reliability was 0.89 to 0.94 and interobserver reli-
ability was 0.85 to 0.93 [22,24]. Subchondral BMLs were
defined as discrete areas of increased signal adjacent to
the subcortical bone at the medial and lateral tibia and
femur on T2-weighted MR images using a semiquan-
titative (0 to 3 scale) scoring system. The intraobserver
reliability ranged between 0.89 to 1.00, as previously de-
scribed [25]. Tibial plateau bone area was determined by
manually measuring on axial T1-weighted MR images, as
previously described [20].
Patellofemoral synovitis was graded semiquantitatively
from 0 to 3 in terms of the signal alterations in IPFP on
T2-weighted MR images at the superior edge of the fatpad adjacent to the patella [26]. Intraobserver reliability
was assessed in 40 subjects with an ICC of 0.91.
Serum biomarker measurements
Serum levels of leptin, IL-6 and TNF-α were measured
in first 193 subjects as described previously [27,28].
Data analysis
Partial correlation analyses were used to examine the asso-
ciations between knee cartilage volume and IPFP area,
and between total tibial bone area and IPFP area. Multi-
variable linear regression was used to analyze the asso-
ciations of IFPF area (the dependent variable) with an
independent variable (age, sex, height, weight, BMI, body
fat, trunk fat, leg muscle strength, patellofemoral synovitis,
leptin, IL-6 or TNF-α) after adjustment for the following
covariates except itself: age, sex, height (not for BMI),
weight (not for BMI, fat measures), tibial bone size, dis-
ease status (diabetes, cardiovascular diseases, asthma,
rheumatoid arthritis) and ROA. Univariable and multivari-
able linear regression analyses were used to examine the
associations between knee cartilage volume/total BML
score (the dependent variable) and IPFP area (the inde-
pendent variable) before and after adjustment for age, sex,
height, weight, tibial bone size, patellofemoral synovitis
and disease status, and further ROA. Univariable and mul-
tivariable binary logistic regression analyses were used to
examine the associations between IPFP area (the inde-
pendent variable) and a dependent variable (knee cartilage
defects, knee JSN, osteophytes, tibial or femoral BMLs, or
WOMAC knee pain) before or after adjustment for the
same covariates. Interactions between sex or ROA and
IPFP area were investigated by regressing cartilage volume
(or others, for example, BMLs) on a binary (0/1) term for
sex (or ROA) within IPFP, and assessed by testing the sta-
tistical significance of the coefficient of a (sex × IPFP) or a
(ROA× IPFP) product term.
Adjustments for multiple testing on regression results
were undertaken using the Hochberg method [29]. A
P-value <0.05 (2-tailed) or a 95% CI not including the null
point (for linear regression) or 1 (for logistic regression)
was considered as statistically significant. All statistical
analyses were performed using SPSS version 20.0 for
Windows (SPSS Inc., Chicago, IL, USA).
Results
A total of 977 subjects between 50 and 80 years of age
(mean, 62.4 years) participated in the present study.
There were no significant differences in demographic
factors (age, sex, and BMI) between these participants
and those excluded (n = 123) (data not shown). Charac-
teristics of the subjects are presented in Table 1. The
mean IPFP area was 7.59 cm2 (SD 1.18, range 4.56 to
12.14). There was a positive association (partial r = 0.26,
Table 1 Baseline characteristics of participants (n = 977)
Characteristic Values*
Age, years 62.4 (7.4)
Sex, female, n (%) 490 (50.2)
Total body fat, kg 27.8 (8.6)
Medial tibial cartilage volume, ml 2.3 (0.6)
Lateral tibial cartilage volume, ml 2.7 (0.7)
Patella cartilage volume, ml 3.2 (0.9)
Medial tibial bone area, cm2 20.9 (3.1)
Lateral tibial bone area, cm2 12.2 (2.2)
Medial joint space narrowing, n (%) 480 (53.0)
Lateral joint space narrowing, n (%) 220 (24.3)
MTF osteophytes, n (%) 65 (7.2)
LTF osteophytes, n (%) 37 (4.1)
BML present, n (%) 348 (35.6)
MTF cartilage defects, n (%) 238 (24.4)
LTF cartilage defects, n (%) 214 (22.0)
Patellar cartilage defects, n (%) 391 (40.1)
Total WOMAC knee pain, n (%) 507 (52.1)
Patellofemoral synovitis, n (%) 243 (26.8)
*Mean (SD), or number (n) of patients (%), as mentioned in the table. BMI, body
mass index; WOMAC, Western Ontario and McMasters osteoarthritis index; BMLs,
bone marrow lesions; MTF, medial tibiofemoral; LTF, lateral tibiofemoral.
Table 2 Association between IPFP area and radiographic
osteoarthritis
Univariable Multivariable*
Odds ratio (95% CI) Odds ratio (95% CI)
Radiographic osteoarthritis 0.88 (0.79,0.99) 0.75(0.62, 0.91)
MTF joint space narrowing 0.87 (0.77,0.97) 0.75 (0.62, 0.91)
LTF joint space narrowing 0.99 (0.88,1.14) 0.77 (0.62, 0.96)
MTF osteophytes 0.87 (0.70,1.09) 0.52 (0.35,0.76)
LTF osteophytes 1.57 (1.19,2.07) 0.64 (0.38,1.08)
*Adjusted for age, sex, height, weight, tibial bone size, diabetes, cardiovascular
diseases, asthma, rheumatoid arthritis, and patellofemoral synovitis. IPFP,
infrapatellar fat pad; MTF, medial tibiofemoral; LTF, lateral tibiofemoral.
Significant differences are shown in bold.
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so all subsequent analyses were adjusted for tibial bone
area.
In multivariable analyses, IPFP area was significantly
and positively associated with age (β: 1.58, 95% CI: 0.80,
2.35), height (β: 6.42, 95% CI: 5.46, 7.38), weight (β: 0.90,
95% CI: 0.47, 1.34), and negatively associated with female
sex (β: −42.59, 95% CI: −59.13, −26.04) after adjustment
for covariates. IPFP area was neither associated with BMI,
body fat, trunk fat, leg muscle strength and patellofemoral
synovitis, nor with leptin, IL-6 and TNF-α (data not
shown).
Table 2 describes the associations between IPFP area
and radiographic OA, JSN, and osteophytes. In univa-
riable analyses, IPFP area was significantly and negatively
associated with prevalence of radiographic OA, but in-
consistently associated with JSN and osteophytes. After
adjustment for age, sex, height, weight, tibial bone size,
patellofemoral synovitis and disease status, larger IPFP
area was significantly associated with reduced radio-
graphic OA, medial JSN, lateral JSN and medial tibio-
femoral osteophytes. The association between IPFP area
and lateral tibiofemoral osteophytes was consistent but
not significant in the multivariable analyses. The changes
in results from univariable to multivariable analyses were
mainly affected by adjustment for tibial bone area.There was a positive association (partial r = 0.20,
P <0.001) between total cartilage volume and IPFP area.
IPFP area was significantly associated with cartilage vol-
ume in all sites in adjusted analyses; and the associations
decreased in magnitude by 17 to 35% but remained sig-
nificant after further adjustment for radiographic OA
(all P <0.001, Table 3). Moreover, though IPFP area was
positively associated with cartilage defects at some sites,
larger IPFP area was significantly associated with reduced
medial and lateral tibial cartilage defects after adjustment
for covariates particularly tibial bone size, and these asso-
ciations became more evident after further adjustment for
radiographic OA (all P <0.01, Table 3). The associations of
IPFP area with femoral and patellar cartilage defects were
negative but did not reach significance (Table 3).
IPFP area was positively associated with BMLs in uni-
variable analyses; however, in multivariable analyses, par-
ticularly after adjustment for tibial bone area, larger IPFP
area was associated with reduced BMLs in all compart-
ments, where increasing per-cm2 area was significantly as-
sociated with 30% and 17% reduced odds of presence of
BMLs at medial femoral and any compartments, respec-
tively. When further adjusted for radiographic OA, the
significant associations remained, and the associations
with medial tibiofemoral and medial tibial BMLs became
significant (Table 4). IPFP area was negatively but non-
significantly associated with lateral tibiofemoral BMLs in
multivariable analyses (Table 4). The association between
IPFP area and total BML scores became negatively sig-
nificant after adjustment for covariates and remained
significant after further adjustment for radiographic OA
(Table 4).
IPFP area was not significantly associated with total knee
pain and pain subscales in univariable analyses; however,
IPFP area was significantly and negatively associated with
pain when walking on a flat surface and going up/down
stairs in multivariable analyses, and remained significant
for pain when walking on a flat surface after further adjust-
ment for radiographic OA (P <0.05, Table 5). IPFP area
Table 3 Associations between IPFP area, cartilage volume and cartilage defects
Univariable Multivariable* Multivariable**
Cartilage volume, β (95% CI)
Medial tibial, ml/cm2 0.27 (0.24, 0.30) 0.09 (0.05, 0.13) 0.06 (0.02, 0.10)
Lateral tibial, ml/cm2 0.34 (0.31, 0.37) 0.11 (0.07, 0.16) 0.08 (0.04, 0.13)
Patellar, ml/cm2 0.44 (0.39, 0.48) 0.20 (0.14, 0.26) 0.16 (0.10, 0.23)
Cartilage defects, odds ratio (95% CI)
Medial tibial 1.15 (0.96, 1.37) 0.72 (0.53, 0.96) 0.58 (0.41, 0.81)
Medial femoral 1.04 (0.91, 1.19) 0.98 (0.79, 1.22) 0.93 (0.74, 1.18)
Lateral tibial 1.00 (0.87, 1.15) 0.66 (0.52, 0.84) 0.53 (0.40, 0.71)
Lateral femoral 1.22 (1.03, 1.45) 0.84 (0.63, 1.11) 0.73 (0.53, 1.00)
Patellar 0.96 (0.86, 1.07) 0.91 (0.76, 1.09) 0.84 (0.69, 1.02)
*Adjusted for age, sex, height, weight, tibial bone size, diabetes, cardiovascular diseases, asthma, rheumatoid arthritis, and patellofemoral synovitis. **Further
adjusted for radiographic osteoarthritis. Significant differences are shown in bold. ml/cm2, with per-cm2 increase in IPFP area, cartilage volume increases in ml.
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knee pain score in multivariable analyses (Table 5).
There were no significant interactions between sex and
IPFP area or between radiographic OA and IPFP area on
the outcomes (cartilage volume, cartilage defects, BMLs)
(data not shown) so male and female subjects or partici-
pants with and without radiographic OA were combined
for analyses. The results remained largely unchanged
when subjects with rheumatoid arthritis were excluded for
analyses (data not shown). All associations (except the as-
sociation with knee pain) remained significant after adjust-
ment for multiple comparisons (data not shown).
Discussion
To our knowledge, this cross-sectional study is the first
to report the significant associations between IPFP area
and clinical and structural abnormalities of the knee
joint in older people. We found consistent evidence that
IPFP area was beneficially associated with radiographicTable 4 Associations between IPFP area and bone marrow les
Un
TF bone marrow lesions, OR (95% CI)
Medial 1.05
Lateral 1.19
Tibial bone marrow lesions, OR (95% CI)
Medial 1.06
Lateral 1.17
Femoral bone marrow lesions, OR (95% CI)
Medial 1.02
Lateral 1.19
Any bone marrow lesions, OR (95% CI) 1.11 (
Bone marrow lesions total score, β (95% CI) (cm2/grade) 0.04 (
*Adjusted for age, sex, height, weight, tibial bone size, diabetes, cardiovascular dise
adjusted for radiographic osteoarthritis. IPFP, infrapatellar fat pad; TF, tibiofemoral;
per-grade increase in bone marrow lesions, IPFP area increases in cm2.OA, knee structural abnormalities and pain. This was in-
dependent of patellofemoral synovitis, body size, tibial
bone area and other covariates, suggesting IPFP area has
an important protective role in knee OA.
In a previous study, Chuckpaiwong et al. [12] mea-
sured IPFP volume using MRI in a cohort of 15 control
subjects and 15 knee OA subjects, and reported that
BMI was not significantly associated with IPFP volume
in either the control or the OA group, and age was
significantly and positively associated with IPFP volume
in the OA group and the whole cohort. Our findings on
age and BMI were consistent with this study, but we
found that weight and height, measures of body size ra-
ther than obesity status, were significantly and positively
associated with IPFP area. Furthermore, we found that
women had a smaller IPFP area than men, and a larger
tibial bone area (a measure of knee size) was associated
with greater IPFP area, providing support for the
construct validity of IPFP area measurement. All theseions
ivariable Multivariable* Multivariable**
(0.92,1.19) 0.83 (0.67, 1.02) 0.74 (0.59,0.93)
(1.04,1.36) 0.93 (0.75, 1.16) 0.91 (0.72,1.16)
(0.92,1.24) 0.87 (0.68, 1.10) 0.74 (0.57,0.96)
(0.94,1.45) 0.84 (0.58,1.20) 0.79 (0.54,1.17)
(0.86,1.22) 0.69 (0.53, 0.92) 0.68 (0.51,0.91)
(1.03,1.38) 0.89 (0.69, 1.13) 0.88 (0.68,1.15)
1.00, 1.24) 0.83 (0.69, 0.99) 0.77 (0.63,0.94)
0.01, 0.08) −0.08 (−0.14, −0.02) −0.11 (−0.17,-0.05)
ases, asthma, rheumatoid arthritis, and patellofemoral synovitis. **Further
OR, odds ratio. Significant differences are shown in bold. cm2/grade: with
Table 5 Associations between IPFP area and prevalent WOMAC knee pain
Univariable Multivariable* Multivariable**
Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI)
Total WOMAC knee pain 0.94 (0.84, 1.04) 0.84 (0.70, 1.00) 0.86 (0.71, 1.04)
Pain on flat surface 0.99 (0.88, 1.12) 0.80 (0.65, 0.98) 0.79 (0.63, 0.98)
Pain on stairs 0.93 (0.83, 1.03) 0.81 (0.67, 0.97) 0.83 (0.69, 1.01)
Pain in bed 0.93 (0.82, 1.04) 0.87 (0.71, 1.05) 0.83 (0.68, 1.03)
Pain when sitting 0.94 (0.83, 1.06) 0.89 (0.73, 1.09) 0.87 (0.70, 1.08)
Pain when standing 1.07 (0.95, 1.20) 1.03 (0.85, 1.26) 0.96 (0.78, 1.19)
*Adjusted for age, sex, height, weight, tibial bone size, diabetes, cardiovascular diseases, asthma, rheumatoid arthritis, and patellofemoral synovitis. **Further
adjusted for radiographic osteoarthritis. WOMAC, Western Ontario and McMasters osteoarthritis index. Significant differences are shown in bold.
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Body mass and/or fat are considered strong risk fac-
tors for knee OA. However, the role of regional fat is
much less clear. The major adipose tissue in the knee
joint is IPFP, and in vitro and animal studies have re-
ported that IPFP can produce inflammatory cytokines
and adipokines that may have detrimental effects on car-
tilage in knee OA [30-32]; in contrast, a meeting abstract
reported that in mice, although high-fat diet increased
IPFP volume, the adipocytes in the IPFP did not become
hypertrophic. IPFP adipocytes may be protected from
obesity-induced macrophage infiltration and inflamma-
tion, suggesting that IPFP is not a source of microphage-
mediated inflammation in a diet-induced obese model of
early-onset knee OA [33]. A recent study reported that
medium conditioned by IPFP from end-stage OA inhi-
bited nitric oxide (NO) production as well as matrix me-
talloproteinase (MMP)-1, MMP-3 and collagen type II
gene expression, and thus may contribute to the in-
hibition of cartilage catabolism [34]. Considering the
intra-articular position of the IPFP with a flexible and
displaceable structure [7], IPFP is likely to absorb force
and reduce overloading of the knee joint, and have a
protective effect on the knee.
Chuckpaiwong et al. [12] reported that there was no dif-
ference in IPFP volume between control and OA groups,
possibly due to a small sample size. In contrast, we found
that IPFP area was significantly and beneficially associated
with cartilage volume and cartilage defects in the current
study. Additionally, IPFP area was associated with de-
creased presence of JSN, an indirect estimate of cartilage
loss on radiography, in both medial and lateral tibiofe-
moral compartments. While these data are cross-sec-
tional, they provide very consistent evidence in support of
a protective effect of local joint fat on articular cartilage,
which is opposite to the effects of systematic fat [35]. We
found that IPFP area was not associated with systematic
fat mass, and metabolic and inflammatory biomarkers,
all of which were associated with increased knee symp-
toms and cartilage loss [15,27,28,36]. This suggests thatsystemic metabolic changes do not necessarily affect the
size of IPFP.
The commonest subchondral bone abnormalities in
knee OA are osteophytes and BMLs. Both are associated
with knee pain [37], cartilage defects and cartilage loss
[38], and need for total knee replacement [39]. In this
study we reported that osteophytes and BMLs were
negatively associated with IPFP area, particularly in the
medial compartment. These findings further support
that IPFP is protective against knee structural changes in
OA.
Abnormalities of some joint structures, such as sub-
chondral bone, capsule, ligaments, meniscus and syno-
vium, have been associated with knee pain. It has been
suggested that the sensory nerves located in these joint
tissues can release substance P, calcitonin gene-related
peptide (CGRP), neuropeptide Y and vasoactive intestinal
peptide (VIP) into the local microenvironment, which act
as the signals of pain [40]. IPFP has been regarded as an
important source of pain in knee OA as it contains sub-
stance P nerve [8]; however, the association between IPFP
and knee pain has not been clarified, though a previous
study reported that IPFP volume was not associated with
knee pain [12]. Our current study demonstrated that the
IPFP area was associated with decreased presence of knee
pain when walking on a flat surface and, and to a lesser
extent, pain when walking upstairs/downstairs, which is
opposite to what was expected, thus it had a protective
effect on mechanical knee pain, which is biologically
plausible.
The reasons underlying the protective effects of IPFP on
joint structures and symptoms are unclear. It may be that
some biochemical factors secreted from IPFP are protec-
tive, because it has been shown that medium conditioned
by OA IPFP inhibits catabolic processes in cartilage [34];
it may most likely be due to the shock-absorbing nature of
IPFP. As we know, biomechanical factors, especially ab-
normal mechanical stress/loading, play an important role
in the initiation and progression of OA [41]. IPFP may
have the same function as meniscus that can reduce
mechanical overloading (especially in knee flexion) and
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joint, which can lead to cartilage degradation) through the
joint. Additionally, IPFP, having the same anatomical loca-
tion as the patellar ligament around the joint, may reduce
instability and injury to the joint, and thus prevent the
onset and progression of OA. Based on these finding, we
conclude that IPFP, especially its size, plays a beneficial
rather than detrimental role in the initiation or progres-
sion of OA. In the clinical setting, the IPFP is often deli-
berately partially or totally resected for clear visualization
of the joint for the surgeons. This study suggests this may
be deleterious.
The main strength of this study is that we selected
participants randomly from the community, with a large
sample size, and obtained both structural and sympto-
matic measurements. This study has several potential
limitations. First, this study measured IPFP area on two-
dimensional T2-weighted MRI, rather than IPFP volume
on three-dimensional T1-weighted MRI. However, the
boundary of IPFP on two-dimensional T2-weighted MRI
is clearer than that on three-dimensional T1-weighted
MRI; also IPFP area was highly correlated to IPFP volume
in our analysis (r = 0.87) (unpublished data). IPFP volume
measurement is also time-consuming. We did not mea-
sure IPFP quality, such as edema and fibrosis, which may
be associated with the progression of OA. Second, mea-
surement error may influence results. However, all mea-
sures were highly reproducible suggesting this is unlikely.
Third, a large number of statistical tests have been per-
formed, which may induce false positive results due to
multiple testing; however, almost all significant associa-
tions remained after adjustment for multiple comparisons.
Though the associations between IPFP area and knee pain
did not pass the Hochberg correction, the consistent asso-
ciations with weight-bearing knee pain subscales (walking
on a flat surface and going up/down stairs) suggest the
findings are biologically plausible, and may not be false
positives. Last, the cross-sectional nature of this study pre-
cludes any inference about cause and effect relationships.
Longitudinal studies are needed to address causality.
Conclusions
In conclusion, IPFP maximum area is beneficially associ-
ated with radiographic OA, MRI structural pathology and
knee pain on a flat surface, suggesting a protective role for
IPFP, possibly through shock absorption. Consequently,
we must pay special attention to IPFP in the clinical set-
ting, avoiding resection of normal IPFP in knee surgery.
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